Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jul 11;4:5672. doi: 10.1038/srep05672

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014, Macmillan Publishers Limited. All rights reserved

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

Heparinized blood samples were obtained from cohort 1 patients with inflammatory myopathies before (Pre-IVIg) and 2–3 days after initiation of IVIg therapy (Post-IVIg). (a) Representative dot-plots showing basophils from cohort 1 patients gated positive for FcεRI and CD203c (b) Modulation of circulating basophils following IVIg therapy (n = 9). Basophils were analyzed in the whole blood by flow cytometry. The statistical significance as determined by two-tailed Student-t-test is indicated, where NS, non-significant. (c) The correlation between fold-changes in IL-33 and basophils following IVIg therapy.